Elpiscience Biopharmaceuticals logo

Elpiscience Biopharmaceuticals

Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies.

32 employees · est. 2017 · Shanghai, China

VS
Huasaiboman Medical Cell Biology logo

Huasaiboman Medical Cell Biology

Pioneering tomorrow's treatments for solid tumors and degenerative diseases through state-of-the-art cell therapy solutions.

est. 2019

Elpiscience Biopharmaceuticals is the older company (2017 vs 2019).

Side-by-Side Comparison

Elpiscience Biopharmaceuticals Huasaiboman Medical Cell Biology
Founded
2017 older 2019
Headquarters
Shanghai, China Not tracked yet
Employees
32 Not tracked yet
Industry
Biopharma, Biotechnology, Health Care Biotechnology, Life Sciences, Pharmaceutical
Funding Stage
Series C Series A
Total Funding
$260.00M Not tracked yet
Funding Rounds
4 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Clinical-stage Biopharmaceutical, Cancer Immunotherapies, Immunosuppressive Factors, Tumor Microenvironment, Adenosine Pathway, Myeloid Checkpoints, Bispecific Macrophage Engager, Solid Tumor Killing, Biopharma Industry, Innovative Molecules, Immuno-oncology, Global Impact, Scientific Innovation, Cancer Patient Benefits, Clinical Advancements Cell Therapy, Tumor Immunotherapy, Stem Cell Therapy, Solid Tumor Treatment, Degenerative Disease Treatment, Clinical Research, Innovative Technology, Immune Cell Drug Products, Tumor Infiltrating Lymphocytes, Research Institute, Collaborative Efforts, Clinical Transformation, Healthcare Innovation, Cancer Treatment
Website
elpiscience.com sino-cellbiomed.com
Elpiscience Biopharmaceuticals logo

About Elpiscience Biopharmaceuticals

Elpiscience Biopharmaceuticals is a clinical-stage biopharmaceutical company with a focus on developing next-generation cancer immunotherapies. Founded in 2017 and headquartered in China, the company is dedicated to developing life-changing immuno-oncology therapies for cancer patients worldwide. Th...

Huasaiboman Medical Cell Biology logo

About Huasaiboman Medical Cell Biology

Huasaiboman Medical Cell Biology is a pioneering company dedicated to developing cutting-edge cell therapy solutions to revolutionize treatments for solid tumors and degenerative diseases. Founded in 2019, the company focuses on integrating clinical research with innovative cell therapy technologies...

We will tell you when either one moves

BounceWatch watches Elpiscience Biopharmaceuticals and Huasaiboman Medical Cell Biology for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Elpiscience Biopharmac... and Huasaiboman Medical Ce... — by email.

Frequently Asked Questions

Elpiscience Biopharmaceuticals — Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies.. Huasaiboman Medical Cell Biology — Pioneering tomorrow's treatments for solid tumors and degenerative diseases through state-of-the-art cell therapy solutions.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Elpiscience Biopharmaceuticals has raised $260.00M while Huasaiboman Medical Cell Biology has raised undisclosed funding.
Elpiscience Biopharmaceuticals and Huasaiboman Medical Cell Biology operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Elpiscience Biopharmaceuticals with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Elpiscience Biopharmaceuticals on 12 Sep 2024, and Huasaiboman Medical Cell Biology on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes